June 20, 2017 | Israeli medical marijuana startup iCAN has announced a joint venture with Australian company LeafCann Research and Advisory. The new venture will take advantage of Israel’s leadership position in the research and development of medical marijuana, in combination with Australia’s lax regulations. Founded in 2015, iCAN is a leading Israeli developer of cannabis-based formulations, clinical trials and cannabis testing. The firm is headed by Saul Kaye.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments